MicroRNAs in glomerular diseases from pathophysiology to potential treatment target

Clinical Science

Volumn 128, Issue 11, 2015, Pages 775-788

  Schena, Francesco P ^a   Sallustio, Fabio ^a,b   Serino, Grazia ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; FIBRINOGEN; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G; MICRORNA; MICRORNA 10B; MICRORNA 141; MICRORNA 143; MICRORNA 146A; MICRORNA 155; MICRORNA 192; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; MICRORNA 21; MICRORNA 223; MICRORNA 29; MICRORNA 29B; MICRORNA 93; N ACETYLGALACTOSAMINYLTRANSFERASE; NEPHRIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PODOCALYXIN; TENSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIMENTIN; WT1 PROTEIN; ANTISENSE OLIGONUCLEOTIDE;

CELL PROLIFERATION; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; HYPERGLYCEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIMARY GLOMERULONEPHRITIS; PRIORITY JOURNAL; REVIEW; SECONDARY GLOMERULONEPHRITIS; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GLOMERULUS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROCEDURES; RNA INTERFERENCE;

GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; MICRORNAS; MOLECULAR TARGETED THERAPY; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE;

EID: 84930989016     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20140733     Document Type: Review

References (72)

1. Witasp, A., Ekström, T.J., Schalling, M., Lindholm, B., Stenvinkel, P. and Nordfors, L. (2014) How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients? Nephrol. Dial. Transplant. 29, 972-980
2. Cox, S.N., Sallustio, F., Serino, G., Pontrelli, P., Verrienti, R., Pesce, F., Torres, D.D., Ancona, N., Stifanelli, P., Zaza, G. and Schena, F.P. (2010) Altered modulation of WNT-β-catenin and PI3K/Akt pathways in IgA nephropathy. Kidney Int. 78, 396-407
3. Argilés, Á., Siwy, J., Duranton, F., Gayrard, N., Dakna, M., Lundin, U., Osaba, L., Delles, C., Mourad, G., Weinberger, K.M. and Mischak, H. (2013) CKD273, a new proteomics classifier assessing CKD and its prognosis. PLoS ONE 8, e62837
4. Del Coco, L., Assfalg, M., D'Onofrio, M., Sallustio, F., Pesce, F., Fanizzi, F.P. and Schena, F.P. (2013) A proton nuclear magnetic resonance-based metabolomic approach in IgA nephropathy urinary profiles. Metabolomics 9, 740-751
5. Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-845
6. Schena, F.P., Serino, G. and Sallustio, F. (2014) MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring. Nephrol. Dial. Transplant. 29, 755-763
7. Chua, J.H., Armugam, A. and Jeyaseelan, K. (2009) MicroRNAs: biogenesis, function and applications. Curr. Opin. Mol. Ther. 11, 189-199
8. Huntzinger, E. and Izaurralde, E. (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99-110
9. Béthune, J., Artus-Revel, C.G. and Filipowicz, W. (2012) Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep. 13, 716-723
10. Djuranovic, S., Nahvi, A. and Green, R. (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336, 237-240
11. Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., Mitchell, P.S., Bennett, C.F., Pogosova-Agadjanyan, E.L., Stirewalt, D.L. et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003-5008
12. Li, J.Y.Z., Yong, T.Y., Michael, M.Z. and Gleadle, J.M. (2010) The role of microRNAs in kidney disease. Nephrology 15, 599-608
13. Bhatt, K., Mi, Q.S. and Dong, Z. (2011) MicroRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am. J. Physiol. Renal Physiol. 300, F602-F610
14. Ho, J. and Kreidberg, J.A. (2012) The long and short of microRNAs in the kidney. J. Am. Soc. Nephrol. 23, 400-404
15. Khella, H.W., Bakhet, M., Lichner, Z., Romaschin, A.D., Jewett, M.A. and Yousef, G.M. (2013) MicroRNAs in kidney disease: an emerging understanding. Am. J. Kidney Dis. 61, 798-808
16. Sun, Y., Koo, S., White, N., Peralta, E., Esau, C., Dean, N.M. and Perera, R.J. (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 32, e188
17. Tian, Z., Greene, A.S., Pietrusz, J.L., Matus, I.R. and Liang, M. (2008) MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res. 18, 404-411
18. Kudo, T., Iwai, T., Kubota, T., Iwasaki, H., Takayma, Y., Hiruma, T., Inaba, N., Zhang, Y., Gotoh, M., Togayachi, A. and Narimatsu, H. (2002) Molecular cloning and characterization of a novel UDP-Gal:GalNAcα peptide β 1, 3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J. Biol. Chem. 277, 47724-47731
19. Iwasaki, H., Zhang, Y., Tachibana, K., Gotoh, M., Kikuchi, N., Kwon, Y.D., Togayachi, A., Kudo, T., Kubota, T. and Narimatsu, H. (2003) Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J. Biol. Chem. 278, 5613-5621
20. Serino, G., Sallustio, F., Cox, S.N., Pesce, F. and Schena, F.P. (2012) Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J. Am. Soc. Nephrol. 23, 814-824
21. Serino, G., Sallustio, F., Curci, C., Cox, S.N., De Palma, G., Pesce, F. and Schena, F.P. (2013) Role of miRNA let-7b in the deregulation process of IgA1 glycosylation in IgA nephropathy. J. Am. Soc. Nephrol. 24, 559A
22. Schena, F.P., Serino, G., Sallustio, F., Pesce, F., De Palma, G., Cox, S.N., Lai, K.N., Leung, J.C.K., Papagianni, A., Stangou, M. et al. (2014) A combined miRNA biomarker for non-invasive diagnosis of idiopathic IgA nephropathy: an international multicentre study (NIDIGAN study). Nephrol. Dial. Transplant. 29, iii42-iii44
23. Wang, G., Kwan, B.C., Lai, F.M., Choi, P.C., Chow, K.M., Li, P.K. and Szeto, C.C. (2010) Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab. Invest. 90, 98-103
24. Gregory, P.A., Bracken, C.P., Bert, A.G. and Goodall, G.J. (2008) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7, 3112-3118
25. Wang, G., Kwan, B.C., Lai, F.M., Chow, K.M., Li, P.K. and Szeto, C.C. (2011) Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis. Markers 30, 171-179
26. Bao, H., Hu, S., Zhang, C., Shi, S., Qin, W., Zeng, C., Zen, K. and Liu, Z. (2014) Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy. Biochem. Biophys. Res. Commun. 444, 455-460
27. Bao, H., Chen, H., Zhu, X., Zhang, M., Yao, G., Yu, Y., Qin, W., Zeng, C., Zen, K. and Liu, Z. (2014) MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy. Kidney Int. 85, 624-635
28. Tan, K., Chen, J., Li, W., Chen, Y., Sui, W., Zhang, Y. and Dai, Y. (2013) Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy. Genome 56, 161-169
29. Fang, Y., Yu, X., Liu, Y., Kriegel, A.J., Heng, Y., Xu, X., Liang, M. and Ding, X. (2013) MiR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. Am. J. Physiol. Renal. Physiol. 304, F1274-F1282
30. Wang, G., Kwan, B.C., Lai, F.M., Chow, K.M., Li, P.K. and Szeto, C.C. (2012) Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis. Am. J. Nephrol. 36, 412-418
31. Szeto, C.C., Ching-Ha, K.B., Ka-Bik, L., Mac-Moune, L.F., Cheung-Lung, C.P., Gang, W., Kai-Ming, C. and Kam-Tao, L.P. (2012) Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis. Markers 33, 137-144
32. Sun, H., Li, Q.W., Lv, X.Y., Ai, J.Z., Yang, Q.T., Duan, J.J., Bian, G.H., Xiao, Y., Wang, Y.D., Zhang, Z. et al. (2010) MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol. Biol. Rep. 37, 2951-2958
33. Wang, G., Kwan, B.C., Lai, F.M., Chow, K.M., Kam-Tao, L.P. and Szeto, C.C. (2010) Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis. Markers 28, 79-86
34. Cai, X., Xia, Z., Zhang, C., Luo, Y., Gao, Y., Fan, Z., Liu, M. and Zhang, Y. (2013) Serum microRNAs levels in primary focal segmental glomerulosclerosis. Pediatr. Nephrol. 28, 1797-1801
35. Wu, J., Zheng, C., Fan, Y., Zeng, C., Chen, Z., Qin, W., Zhang, C., Zhang, W., Wang, X., Zhu, X. et al. (2014) Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J. Am. Soc. Nephrol. 25, 92-104
36. Gebeshuber, C.A., Kornauth, C., Dong, L., Sierig, R., Seibler, J., Reiss, M., Tauber, S, Bilban, M., Wang, S., Kain, R. et al. (2013) Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat. Med. 19, 481-487
37. Ohtaka, A., Ootaka, T., Sato, H. and Ito, S. (2002) Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm? Nephrol. Dial. Transplant. 17 (Suppl. 9), 11-15
38. Wang, G., Kwan, B.C., Lai, F.M., Chow, K.M., Li, P.K. and Szeto, C.C. (2013) Urinary sediment miRNA levels in adult nephrotic syndrome. Clin. Chim. Acta 418, 5-11
39. Dai, Y., Huang, Y.S., Tang, M., Lv, T.Y., Hu, C.X., Tan, Y.H., Xu, Z.M. and Yin, Y.B. (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16, 939-946
40. Te, J.L., Dozmorov, I.M., Guthridge, J.M., Nguyen, K.L., Cavett, J.W., Kelly, J. A., Bruner, G.R., Harley, J.B. and Ojwang, J.O. (2010) Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 5, e10344
41. Pan, W., Zhu, S., Yuan, M., Cui, H., Wang, L., Luo, X., Li, J., Zhou, H., Tang, Y. and Shen, N. (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184, 6733-6781
42. Zhao, S., Wang, Y., Liang, Y., Zhao, M., Long, H., Ding, S., Yin, H. and Lu, Q. (2011) MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 63, 1376-1386
43. Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P.P. et al. (2009) MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60, 1065-1075
44. Luo, X., Yang, W., Ye, D.Q., Cui, H., Zhang, Y., Hirankarn, N., Qian, X., Tang, Y., Lau, Y.L., de Vries, N. et al. (2011) A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 7, e1002128
45. Pan, Y., Jia, T., Zhang, Y., Zhang, K., Zhang, R., Li, J. and Wang, L. (2012) MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int. J. Nanomed. 7, 5957-5967
46. Zhao, X., Tang, Y., Qu, B., Cui, H., Wang, S., Wang, L., Luo, X., Huang, X., Li, J., Chen, S. and Shen, N. (2010) MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 62, 3425-3435
47. Divekar, A.A., Dubey, S., Gangalum, P.R. and Singh, R.R. (2011) Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J. Immunol. 15, 924-930
48. Wang, G., Tam, L.S., Li, E.K., Kwan, B.C., Chow, K.M., Luk, C.C., Li, P.K. and Szeto, C.C. (2011) Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20, 493-500
49. Wang, G., Tam, L.S., Li, E.K., Kwan, B.C., Chow, K.M., Luk, C.C., Li, P.K. and Szeto, C.C. (2010) Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J. Rheumatol. 37, 2516-2522
50. Wang, H., Peng, W., Ouyang, X., Li, W. and Dai, Y. (2012) Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 160, 198-206
51. Carlsen, A.L., Schetter, A.J., Nielsen, C.T., Lood, C., Knudsen, S., Voss, A., Harris, C.C., Hellmark, T., Segelmark, M., Jacobsen, S. et al. (2013) Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 65, 1324-1334
52. Dai, Y., Sui, W., Lan, H., Yan, Q., Huang, H. and Huang, Y. (2009) Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int. 29, 749-754
53. Lu, J., Kwan, B.C., Lai, F.M., Tam, L.S., Li, E.K., Chow, K.M., Wang, G., Li, P.K. and Szeto, C.C. (2012) Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology 17, 346-351
54. Zhou, H., Hasni, S.A., Perez, P., Tandon, M., Jang, S., Zheng, C., Kopp, J.B., Austin, 3rd, H., Balow, J.E., Alevizos, I. and Illei, G.G. (2013) MiR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J. Am. Soc. Nephrol. 24, 1073-1087
55. Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J.J. and Natarajan, R. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U.S.A. 104, 3432-3437
56. Putta, S., Lanting, L., Sun, G., Lawson, G., Kato, M. and Natarajan, R. (2012) Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 23, 458-469
57. Wang, B., Herman-Edelstein, M., Koh, P., Burns, W., Jandeleit-Dahm, K., Watson, A., Saleem, M., Goodall, G.J., Twigg, S.M., Cooper, M.E. and Kantharidis, P. (2010) E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-β. Diabetes 59, 1794-1802
58. Krupa, A., Jenkins, R., Luo, D.D., Lewis, A., Phillips, A. and Fraser, D. (2010) Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 21, 438-447
59. Wang, Q., Wang, Y., Minto, A.W., Wang, J., Shi, Q., Li, X. and Quigg, R.J. (2008) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 22, 4126-4135
60. Long, J., Wang, Y., Wang, W., Chang, B.H. and Danesh, F.R. (2011) MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 286, 11837-11848
61. Long, J., Wang, Y., Wang, W., Chang, B.H. and Danesh, F.R. (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 285, 23457-23465
62. Kato, M., Arce, L., Wang, M., Putta, S., Lanting, L. and Natarajan, R. (2011) A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney Int. 80, 358-368
63. Kato, M., Wang, L., Putta, S., Wang, M., Yuan, H., Sun, G., Lanting, L., Todorov, I., Rossi, J.J. and Natarajan, R. (2010) Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-β-induced collagen expression in kidney cells. J. Biol. Chem. 285, 34004-34015
64. Dey, N., Das, F., Mariappan, M.M., Mandal, C.C., Ghosh-Choudhury, N., Kasinath, B.S. and Choudhury, G.G. (2011) MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J. Biol. Chem. 286, 25586-25603
65. Wang, J.Y., Gao, Y.B., Zhang, N., Zou, D.W., Wang, P., Zhu, Z.Y., Li, J.Y., Zhou, S.N., Wang, S.C., Wang, Y.Y. and Yang, J.K. (2014) MiR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol. Cell. Endocrinol. 392, 163-172
66. Zhang, Z., Peng, H., Chen, J., Chen, X., Han, F., Xu, X., He, X. and Yan, N. (2009) MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 583, 2009-2014
67. Alvarez, M.L., Khosroheidari, M., Eddy, E. and Kiefer, J. (2013) Role of microRNA 1207-5p and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS ONE 8, e77468
68. Fu, Y., Zhang, Y., Wang, Z., Wang, L., Wei, X., Zhang, B., Wen, Z., Fang, H., Pang, Q. and Yi, F. (2010) Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am. J. Nephrol. 32, 581-589
69. Wang, B., Koh, P., Winbanks, C., Coughlan, M.T., McClelland, A., Watson, A., Jandeleit-Dahm, K., Burns, W.C., Thomas, M.C., Cooper, M.E. and Kantharidis, P. (2011) MiR-200a prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 60, 280-287
70. Zhang, Z., Luo, X., Ding, S., Chen, J., Chen, T., Chen, X., Zha, H., Yao, L., He, X. and Peng, H. (2012) MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett. 586, 20-26
71. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A. et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518
72. Qin, W., Chung, A.C., Huang, X.R., Meng, X.M., Hui, D.S., Yu, C.M., Sung, J.J. and Lan, H.Y. (2011) TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 22, 1462-1474